Earnings call briefThird-quarter 2026
Stryker now expects adjusted other income and expense of about $400 million for 2026
Stryker said it expects fourth-quarter organic sales growth similar to the third quarter's 7.7%, assuming the procedure environment and continued capital demand continue.
GetSignal Stryker SYK
Stryker said on its third-quarter call that it now expects adjusted other income and expense of approximately $400 million for the full year. It also expects a full-year effective tax rate of 15.5% to 16%.
Chair and Chief Executive Officer Kevin Lobo said hip and knee market growth is in the 2.5% range this year, a step down from the last five to six years.
Quotes from the call
“We now expect adjusted other income and expense to be approximately $400 million for the full year.”
Key facts from the call
- Expected full-year adjusted other income and expense
- Approximately $400 million
- Expected full-year effective tax rate
- 15.5% to 16%
- Expected fourth-quarter organic sales growth
- Similar to the third quarter's 7.7%, assuming the procedure environment and continued capital demand continue
- Company's estimate of hip and knee market growth this year
- Roughly 2.5%
Source: Stryker's third-quarter 2026 earnings call, October 29, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.
More earnings call briefs
- Stryker narrows 2026 guidance and plans to resume share repurchases
SYK Stryker Q2 2026 call
- Constellation Energy expects nuclear uprate costs of about $4.3 billion
CEG Constellation Energy Q3 2026 call
- Howard Hughes Holdings says its insurance ambition is a return on equity in excess of 20%
HHH Howard Hughes Holdings Q3 2026 call
- Brookfield Asset Management now sees 2026 earnings modestly below early view
BAM Brookfield Asset Management Q3 2026 call
- Enbridge says it expects 2026 results at the midpoint of its guidance range
ENB Enbridge Q3 2026 call
